Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Acorda Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 36 | 36 | 0 |
| Shares | 6.28M | 5.36M | −916.8K (−14.6%) |
| Value | $1.91M | $4.09M | +$2.18M (+113.9%) |
New holders (4)
Institutions that held Acorda Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 132,500 | $102.0K | 0.24% |
| Deutsche Bank AG | 34,000 | $26.1K | 0.00% |
| Group One Trading, L.P. | 9,547 | $7.32K | 0.00% |
| Rockefeller Capital Management L.P. | 167 | $0 | 0.00% |
Sold out (4)
Institutions that held Acorda Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Canyon Capital Advisors LLC | 1,193,988 | $357.0K |
| Virtu Financial LLC | 21,417 | $6.00K |
| BNP Paribas Arbitrage, SA | 607 | $181 |
| Bank of America Corp | 1 | $0 |